Stock listing

Shanghai:688222 Hitgen Inc. (成都先导) 股价

Follow Hitgen Inc. into a list and get an email when it puts out news.

Share price · SSE:688222

¥25.87 CNY -3.18 (-10.9%)

Close on Nov 20, 2026

Past year +15.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
¥25.42 – ¥27.12 CNYNov 20, 2026
Volume
21.45M sharesNov 20, 2026
Market cap
¥10.38B CNYAt the close on Nov 20, 2026 · price × 401.2M shares outstanding
52-week range
¥21.46 – ¥47.58 CNYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
¥861.8M CNYMedian day 22.58M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Hitgen Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SSE:688222 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥25.87-3.18-10.9%¥26.00¥27.12¥25.4221,447,019
¥29.05-5.85-16.8%¥35.00¥35.29¥28.8834,221,928
¥34.90+0.25+0.7%¥34.39¥35.91¥33.9016,164,414
¥34.65-3.34-8.8%¥37.10¥37.70¥34.3320,888,874
¥37.99-2.86-7.0%¥40.17¥40.21¥37.0030,091,929
¥40.85+2.03+5.2%¥38.99¥41.66¥38.5335,412,376
¥38.82+1.52+4.1%¥36.79¥38.85¥36.3723,547,794
¥37.30+0.38+1.0%¥38.00¥38.48¥36.4822,072,721
¥36.92+1.75+5.0%¥35.60¥37.89¥35.6025,823,655
¥35.17-3.15-8.2%¥36.50¥38.00¥35.0928,910,500
¥38.32+2.71+7.6%¥35.00¥39.50¥34.8035,845,137
¥35.61+2.05+6.1%¥33.25¥36.10¥31.2232,222,515
¥33.56-3.95-10.5%¥36.86¥36.92¥33.5028,942,733
¥37.51+0.76+2.1%¥36.30¥37.81¥34.7829,599,976
¥36.75+0.32+0.9%¥35.53¥39.90¥33.3835,584,745
¥36.43-0.02-0.1%¥36.48¥37.96¥35.7529,663,916
¥36.45+2.96+8.8%¥34.03¥36.97¥33.6125,429,629
¥33.49-1.79-5.1%¥35.85¥36.18¥33.4517,234,205
¥35.28-1.80-4.9%¥36.68¥37.48¥35.1519,793,787
¥37.08+1.88+5.3%¥34.50¥37.60¥33.3524,706,587
¥35.20-1.94-5.2%¥37.05¥37.99¥35.0023,572,449
¥37.14-0.54-1.4%¥38.00¥38.80¥36.7623,514,616
¥37.68+1.70+4.7%¥35.73¥38.77¥34.8128,502,354
¥35.98+0.35+1.0%¥36.21¥37.68¥33.5824,016,059
¥35.63-0.52-1.4%¥37.43¥40.32¥35.2426,063,935
¥36.15-0.86-2.3%¥35.81¥38.12¥35.6116,440,410
¥37.01-1.35-3.5%¥38.36¥38.93¥37.0112,319,215
¥38.36-0.62-1.6%¥38.00¥38.96¥36.5716,069,105
¥38.98-2.47-6.0%¥41.89¥42.50¥38.9816,392,864
¥41.45-0.47-1.1%¥41.74¥42.44¥39.2221,803,508
¥41.92-2.77-6.2%¥43.83¥44.02¥41.7224,404,907
¥44.69+1.01+2.3%¥43.50¥46.22¥42.8127,817,271
¥43.680.000.0%¥43.00¥45.18¥42.1519,647,524
¥43.68-0.51-1.2%¥44.50¥44.70¥42.6121,846,826
¥44.19-1.83-4.0%¥45.55¥46.30¥44.1923,089,787
¥46.02+1.62+3.6%¥44.48¥47.58¥43.5134,039,474
¥44.40-1.08-2.4%¥45.58¥45.83¥43.8036,652,145
¥45.48+5.51+13.8%¥41.65¥46.56¥40.7844,390,938
¥39.97+2.29+6.1%¥39.00¥41.64¥38.3037,562,150
¥37.68+1.06+2.9%¥36.46¥37.90¥35.8327,040,691
¥36.62+4.51+14.0%¥32.18¥37.19¥31.7530,684,613
¥32.11-0.38-1.2%¥32.40¥32.80¥31.969,863,593
¥32.49+2.00+6.6%¥30.34¥32.70¥30.2114,400,525
¥30.49-0.78-2.5%¥30.69¥31.12¥29.6011,185,874
¥31.27-1.13-3.5%¥32.11¥32.13¥30.8812,113,727
¥32.40-0.05-0.2%¥31.89¥33.30¥31.7219,468,406
¥32.45+0.86+2.7%¥31.66¥32.65¥31.1319,797,185
¥31.59+0.15+0.5%¥31.97¥32.29¥31.3510,721,359
¥31.44-0.97-3.0%¥32.70¥32.89¥31.1315,351,798
¥32.41+0.04+0.1%¥32.40¥33.00¥31.5813,575,685
¥32.37-0.06-0.2%¥32.47¥32.98¥31.7016,871,672
¥32.43+0.19+0.6%¥32.06¥32.91¥31.5013,979,236
¥32.24-0.62-1.9%¥31.01¥32.34¥30.9016,937,422
¥32.86-0.86-2.6%¥33.65¥34.55¥32.8116,350,367
¥33.72-0.09-0.3%¥34.79¥35.34¥32.9318,893,289
¥33.81-1.12-3.2%¥34.88¥35.48¥33.4417,680,281
¥34.93+0.25+0.7%¥34.34¥35.53¥33.6319,059,939
¥34.68-1.48-4.1%¥36.63¥37.25¥34.2416,207,078
¥36.16-2.54-6.6%¥37.16¥38.00¥35.6624,474,052
¥38.70+3.55+10.1%¥38.00¥40.57¥36.6832,593,295
Ticker
Shanghai:688222
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

(688222)"HitGen Inc."Report for Q3 2026

Oct 29, 2026

Closed ¥36.43 (-0.1%) on Oct 29, 2026

All Hitgen Inc. news

Hitgen Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
33 in the last 12 months · 67 in all · newest Nov 3, 2026 · oldest 2021

Valuation

EV/sales 13.6× against a median of 52.7×: 3rd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
¥9.58B CNY
P/E
66.5×
EV/sales
13.6×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
6.5×
Gross margin
57.1%
Operating margin
30.0%
Net margin
22.1%
Debt to equity
0.2×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Hitgen Inc. Class A · SSE:688222US$1.56BUS$1.44B66.5×13.6×n/a6.5×22.1%0.2×n/a
Zenas BioPharma, Inc. · NASDAQ:ZBIOUS$1.62BUS$1.26Bn/a114×n/a7.6×n/a1.1×1.05
Recursion Pharmaceuticals, Inc. · NASDAQ:RXRXUS$1.53BUS$987.7Mn/a14.5×n/a1.7×−697.1%0.0×2.83
Alvotech · NASDAQ:ALVOUS$1.47BUS$2.78Bn/a5.7×31.4×n/a−36.5%n/a0.90
ABL Bio, Inc. · KRX:298380US$1.47BUS$1.34Bn/a52.7×n/a11.5×−229.4%0.0×n/a
PELL Bio-Med Technology Co Ltd · TWSE:6949US$1.46BUS$1.40Bn/a1,591×n/a18.7×n/a0.1×n/a
Mesoblast Limited · ASX:MSBUS$1.46BUS$1.42Bn/a82.4×n/a2.4×−593.9%0.2×n/a
Damora Therapeutics, Inc. · NASDAQ:DMRAUS$1.44BUS$910.0Mn/an/an/a2.9×n/a0.0×0.88
Vir Biotechnology, Inc. · NASDAQ:VIRUS$1.44BUS$1.07Bn/a3.5×n/a1.6×−61.0%0.1×1.82
Voronoi, Inc. · KRX:310210US$1.44BUS$1.39Bn/an/an/a27.9×n/a0.5×n/a
Kailera Therapeutics, Inc. · NASDAQ:KLRAUS$1.43BUS$539.5Mn/an/an/a1.4×n/a0.0×1.28
Median of the othersUS$1.46BUS$1.30B52.7×31.4×2.9×−229.4%0.1×1.17

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
45.10 CNY · Analysts' mean
EPS, year to Dec 2026
0.40 · 1 analyst
Revenue, year to Dec 2026
712.3M · 2 analysts

Team and board

Officers

OfficerRole
Jin LiChairman&CEO
Hongge LiuChief Financial Officer
Shiwei GengBoard Secretary
Dengfeng DouVice President
Guansai LiuSenior Vice President
JJ ChenVice President
Shimiao YuVice President

Board

DirectorRole
Jin LiChairman&CEO
Suibo Li 董事Director

Events

QuarterResultsShare move
Q3 2026Oct 28, 2026 · Before open+8.8%
Q1 2023Apr 28, 2023 · Before open+5.4%
Q3 2022Oct 28, 2022 · Before open−3.1%
Q2 2022Aug 26, 2022 · After close−11.7%
Q1 2022Apr 28, 2022 · After close+5.3%
Quarter to Sep 30, 2021Oct 29, 2021 · Before open+0.6%
Quarter to Jun 30, 2021Aug 27, 2021 · After close+9.3%
Quarter to Mar 31, 2021Apr 29, 2021 · After close−2.0%
Q4 2020Feb 26, 2021 · Before open+3.5%

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue525.6M427.0M371.3M329.7M311.1M243.6M264.2M
Cost of revenue240.6M205.5M188.5M172.5M164.8M50.3M48.7M
Gross profit285.0M221.4M182.9M157.2M146.3M193.3M215.4M
Research and development71.6M67.3M79.6M87.4M73.7M99.9M91.5M
Selling, general and administrative33.3M25.2M24.8M23.4M21.3M17.4M26.4M
Operating income132.7M86.6M34.3M-5.01M35.2M62.4M124.0M
Depreciation and amortization48.0M45.8M45.3M44.3M45.4M19.0M13.3M
EBITDA180.7M132.3M79.6M39.3M80.7M81.3M137.3M
Interest expense11.3M13.0M13.0M9.83M6.56M839.2K572.6K
Income before tax120.9M62.8M35.4M12.4M55.8M63.4M132.8M
Net income109.5M51.4M40.7M25.3M63.4M64.0M120.3M
Earnings per share, basic0.270.130.100.060.160.160.33

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents624.0M462.2M377.4M358.0M373.7M430.1M334.3M
Short-term investments340.0M500.0M580.1M542.0M601.0M65.0M
Receivables106.1M99.3M96.8M96.9M76.4M61.6M33.1M
Inventory40.9M33.4M28.2M25.3M24.9M24.5M13.1M
Current assets1.21B1.19B1.18B1.15B1.19B1.15B487.4M
Goodwill119.4M58.7M58.5M65.6M79.3M81.9M
Total assets1.95B1.76B1.73B1.67B1.71B1.69B635.4M
Accounts payable42.5M18.0M11.3M18.6M53.6M10.8M11.1M
Current liabilities256.2M188.7M86.0M73.8M127.1M222.4M73.0M
Long-term debt138.5M93.5M193.7M197.5M194.1M101.1M
Total liabilities447.3M334.0M346.6M341.7M397.9M407.3M123.6M
Shareholders' equity1.50B1.39B1.36B1.30B1.32B1.28B511.8M
Shares outstanding400.7M400.7M400.7M400.7M400.7M400.7M360.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations216.3M128.0M125.2M52.7M43.5M1.59M168.3M
Capital spending-160.5M-71.7M-53.7M-87.3M-139.9M-82.7M-61.3M
Free cash flow55.8M56.3M71.5M-34.6M-96.4M-81.1M106.9M
Dividends paid-34.0M-31.3M-11.0M-27.6M-23.6M-50.3M
Change in cash159.8M88.0M16.2M10.9M-83.1M94.3M129.5M

Open Financials

Filings

FilingDateTypeFiled with
(688222)"HitGen Inc."Announcement on Introduction of Investor by Investee Company and Passive Formation of Related Party TransactionNov 3, 2026Acquisition or disposalShanghai Stock Exchange
(688222)"HitGen Inc."Announcement on Change of Registered Capital, Amendment to the Articles of Association and Filing of Industrial and Commercial Registration ChangesOct 29, 2026Other filingsShanghai Stock Exchange
(688222)"HitGen Inc."Report for Q3 2026Oct 29, 2026Quarterly reportShanghai Stock Exchange
(688222)"HitGen Inc."Announcement on Convening the Q3 2026 Performance BriefingOct 29, 2026Meeting noticeShanghai Stock Exchange
"HitGen Inc."Announcement on Issuance Results of the 1st Tranche of Sci-Tech Innovation Bonds for 2026Sep 28, 2026Other filingsShanghai Stock Exchange
"HitGen Inc."Announcement on Vesting Results for the First Vesting Period under the 2025 Restricted Share Incentive Plan and Listing of SharesSep 23, 2026ResultsShanghai Stock Exchange
"HitGen Inc."Announcement on Receipt of the Notice of Registration Acceptance from the National Association of Financial Market Institutional InvestorsSep 7, 2026FinancingShanghai Stock Exchange
"HitGen Inc."Announcement on Shareholding Reduction Plan of Shareholder Shenzhen Juntian Investment Enterprise (Limited Partnership)Aug 28, 2026Ownership change noticeShanghai Stock Exchange
"HitGen Inc."Announcement on Resolutions of the 9th Meeting of the 3rd Board of DirectorsAug 26, 2026Meeting outcomeShanghai Stock Exchange
"HitGen Inc."Announcement on Results of Shareholding Reduction by Shareholder Shenzhen Juntian Investment Enterprise (Limited Partnership)Aug 13, 2026Other filingsShanghai Stock Exchange
All 58 filings
FilingDateTypeFiled with
"HitGen Inc."Announcement on Developing Certain Corporate Governance PoliciesJul 10, 2026Other filingsShanghai Stock Exchange
"HitGen Inc."Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 5%Jul 1, 2026Ownership change noticeShanghai Stock Exchange
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Jun 24, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Implementation of Dividend Distribution for 2025Jun 11, 2026DividendShanghai Stock Exchange
Notice on Convening the 2nd Extraordinary General Meeting in 2026Jun 3, 2026Meeting noticeShanghai Stock Exchange
Announcement on Resolutions of the 2025 Annual General MeetingMay 29, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Progress in Capital Increase in Joint-stock Companies and Completion of Industrial and Commercial Change RegistrationMay 22, 2026Operations updateShanghai Stock Exchange
Announcement on Shareholding Reduction Plan for ShareholdersMay 7, 2026Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 6th Meeting of the 3rd Board of DirectorsApr 28, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Shareholding Reduction Results for Shareholder Shenzhen Juntian Investment Enterprise (Limited Partnership)Apr 21, 2026Ownership change noticeShanghai Stock Exchange
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Mar 2, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Preliminary Earnings Estimate for 2025Feb 27, 2026ResultsShanghai Stock Exchange
Notice on Convening the 1st Extraordinary General Meeting in 2026Feb 11, 2026Meeting noticeShanghai Stock Exchange
Announcement on Capital Increase in a Joint-stock Company and Related Party TransactionsFeb 10, 2026Acquisition or disposalShanghai Stock Exchange
Announcement on the Completion and Results of the Share Increase Plan by Ningbo Juzhi Pioneer Biotechnology Partnership Enterprise (Limited Partnership), a Person Acting in Concert of the Controlling Shareholder and the Actual ControllerJan 30, 2026Ownership change noticeShanghai Stock Exchange
Announcement on Expected Increase in Performance for 2025Jan 27, 2026GuidanceShanghai Stock Exchange
Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership PlanJan 26, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Completion of Non-trading Transfer under the 2025 Employee Stock Ownership PlanDec 26, 2025Other filingsShanghai Stock Exchange
Announcement on Outward InvestmentDec 19, 2025Acquisition or disposalShanghai Stock Exchange
Announcement on Results of Shareholding Reduction by Shareholder Lhasa Economic and Technological Development Zone Huabo Medical Equipment Co., Ltd.Nov 24, 2025Ownership change noticeShanghai Stock Exchange
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Nov 14, 2025Meeting outcomeShanghai Stock Exchange
Announcement on Convening the Q3 2025 Performance BriefingNov 10, 2025Meeting noticeShanghai Stock Exchange
Report for Q3 2025Oct 29, 2025Quarterly reportShanghai Stock Exchange
Board of Supervisors' Verification Opinions and Publicity Explanation on List of Proposed Incentive Objects in 2025 Restricted Stock Incentive PlanSep 8, 2025Other filingsShanghai Stock Exchange
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleSep 4, 2025Other filingsShanghai Stock Exchange
Announcement on Abnormal Fluctuations in Stock TradingJul 21, 2025Other filingsShanghai Stock Exchange
Indicative Announcement on Terminating Major Asset RestructuringJun 29, 2025Other filingsShanghai Stock Exchange
Indicative Announcement on Changes in Equity of Shareholder with Over 5% Shares and Results of Shareholding ReductionJun 23, 2025Other filingsShanghai Stock Exchange
Announcement on Result of Share Reduction by Shareholder Huabo Medical Device Co., Ltd., Lhasa Economic and Technological Development ZoneJun 19, 2025Other filingsShanghai Stock Exchange
Announcement on Providing Guarantee for Wholly-owned SubsidiaryJun 18, 2025Other filingsShanghai Stock Exchange
Announcement on Implementation of Dividend Distribution for 2024Jun 11, 2025DividendShanghai Stock Exchange
Announcement on Progress in Planning Major Asset RestructuringMay 29, 2025Other filingsShanghai Stock Exchange
Indicative Announcement on Equity Change of Shareholder Anji Dongfang Jiayu Enterprise Management Partnership (Limited Partnership) with Over 5% Shares Reaching 1% ScaleMay 26, 2025Other filingsShanghai Stock Exchange
Indicative Announcement on Postponing Term Change of the Board of Directors and the Board of Supervisors and Proposing Resignation by Independent Director upon Expiration of TermMay 23, 2025Management or board changeShanghai Stock Exchange
Announcement on Share Increase Plan of Ningbo Juzhi Pioneer Biotechnology Partnership Enterprise (Limited Partnership)May 22, 2025Other filingsShanghai Stock Exchange
2024 Annual ReportApr 25, 2025Annual reportShanghai Stock Exchange
Indicative Announcement on Planning Major Asset Restructuring and Signing Letter of Intent for Equity AcquisitionMar 31, 2025Acquisition or disposalShanghai Stock Exchange
Announcement on Share Reduction Plan for ShareholdersMar 2, 2025Other filingsShanghai Stock Exchange
Announcement on Preliminary Earnings Estimate for 2024Feb 27, 2025Other filingsShanghai Stock Exchange
Announcement on Shareholding Reduction Results for Shareholder Chongqing Boyi Xintian Equity Investment Fund Partnership (L.P.)Feb 14, 2025Other filingsShanghai Stock Exchange
Announcement on the Result of Shareholding Reduction through Call Auction for Shareholder CS Venture Capital Co., Ltd.Dec 27, 2024Other filingsShanghai Stock Exchange
Announcement on Shareholding Reduction Plan for Shareholders CS Venture Capital Co., Ltd. and Chongqing Boyi Xintian Equity Investment Fund Partnership (L.P.)Nov 19, 2024Other filingsShanghai Stock Exchange
Announcement on Convening the Q3 2024 Performance BriefingOct 31, 2024Other filingsShanghai Stock Exchange
Report for Q3 2024Oct 25, 2024Other filingsShanghai Stock Exchange
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024Sep 13, 2024Meeting noticeShanghai Stock Exchange
Announcement on Obtaining Government GrantsSep 12, 2024Other filingsShanghai Stock Exchange
Announcement on Convening the 2024 Semi-annual Performance BriefingSep 9, 2024Other filingsShanghai Stock Exchange
Announcement on Renewing Engagement of Financial Audit Institution and Internal Control Audit Institution for 2024Aug 28, 2024Other filingsShanghai Stock Exchange

Open Filings

Cap table

Built by 6ix from Hitgen Inc. Class A’s releases

Common shares
401,172,710
Fully diluted
401,172,710

Fully diluted

LineShares
Common shares401,172,710

Share count over time

CountShares
Nov 22, 2026401,172,710

Open Cap table

Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dengfeng DouVice President · Since at least Nov 6, 2026
Guansai LiuSenior Vice President · Since at least Nov 6, 2026
Hongge LiuChief Financial Officer · Since at least Nov 6, 2026
Jin LiChairman&CEO · Since at least Apr 29, 2026
JJ ChenVice President · Since at least Nov 6, 2026
Shimiao YuVice President · Since at least Nov 6, 2026
Shiwei GengBoard Secretary · Since at least Nov 6, 2026
Suibo LiDirector · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Hitgen Inc.